Janice E. Chin

5.3k citations

22 papers · 4.4k indexed · 4 hit papers · h-index 18

Impact in

Oncology top 0.5%
- Drug Transport and Resistance Mechanisms
Molecular Biology top 5%
- Cancer therapeutics and mechanisms
- RNA Interference and Gene Delivery
- DNA and Nucleic Acid Chemistry
- DNA Repair Mechanisms

Papers in

Aging 1
Oncology 12
- Drug Transport and Resistance Mechanisms 10
- Peptidase Inhibition and Analysis 2

Co-authors: Igor B. Roninson Michael M. Gottesman Ira Pastan Douglas P. Clark Kazumitsu Ueda Antonio Tito Fojo Donglai Shen Kevin E. Noonan
Journals: Molecular and Cellular Biology (4 papers)Proceedings of the National Academy of Sciences (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of Medicinal Chemistry (2 papers)Molecular Therapy (1 paper)
Partner nations: United States Brazil India

In The Last Decade

Janice E. Chin

21 papers receiving 4.3k citations

Hit Papers

align trajectories log scale

Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. 1990 · 660 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1990 Proceedings of the National Academy of Sciences
1986 Cell
1986 Science
1986 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Janice E. Chin

Since Specialization

Citations

This map shows the geographic impact of Janice E. Chin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janice E. Chin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janice E. Chin more than expected).

Fields of papers citing papers by Janice E. Chin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janice E. Chin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janice E. Chin. The network helps show where Janice E. Chin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Janice E. Chin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Janice E. Chin Line = papers co-authored together Janice E. Chin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Safety, Pharmacokinetics, and Activity of AT-752, a Novel Nucleotide Prodrug with Pan-Serotype Activity against Dengue Virus: A Phase 2, Randomized, Double-Blind Study American Journal of Tropical Medicine and Hygiene ·J D Sargent, Mauro Martins Teixeira, Nai-Fan Huo, 位光川端, Janice E. Chin, Laura Ishak, اطهر مرادی, Keith Pietropaolo, Bruce Belanger, Lei Yang, Qi Huang, Janet Hammond	2025	0
2	Finding Bugs with Specification-Based Testing is Easy! arXiv (Cornell University) ·Janice E. Chin, David J. Pearce	2021	2
3	PDE10A Inhibition Reduces the Manifestation of Pathology in DMD Zebrafish and Represses the Genetic Modifier PITPNA Molecular Therapy ·M.M. Stanciu, Janelle M. Spinazzola, Jeffrey J. Widrick, Козлов Сергей Николаевич, А Е Зверовщиков, Janice E. Chin, Jane Owens, Louis M. Kunkel	2020	13
4	Histone deacetylase inhibitors derived from 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine and related heterocycles selective for the HDAC6 isoform Bioorganic & Medicinal Chemistry Letters ·Christopher Blackburn, RichardNgendabanyikwa RichardNgendabanyikwa, Frank Veyder, Janice E. Chin, Dylan B. England, M. Allen-Wytzes, Kenneth M. Gigstad, Alexandra E. Gould, Juan A. Gutierrez, Kara M. Hoar, R. Scott Rowland, Christopher Tsu, Shishita Jahan Zisha, Amani Kaawan, He N. Xu	2014	13
5	Discovery of 5-phenoxy-1,3-dimethyl-1H-pyrazole-4-carboxamides as potent agonists of TGR5 via sequential combinatorial libraries Bioorganic & Medicinal Chemistry Letters ·Allyn T. Londregan, David W. Piotrowski, Kentaro Futatsugi, Joseph S. Warmus, Markus Boehm, Philip A. Carpino, Janice E. Chin, Y Saiki, Felipe dos Santos Lazzari, Joanne Buxton, Terri Hinchey	2013	20
6	Potent Histone Deacetylase Inhibitors Derived from 4-(Aminomethyl)-N-hydroxybenzamide with High Selectivity for the HDAC6 Isoform Journal of Medicinal Chemistry ·Christopher Blackburn, RichardNgendabanyikwa RichardNgendabanyikwa, Janice E. Chin, M. Allen-Wytzes, Kenneth M. Gigstad, Alexandra E. Gould, Juan A. Gutierrez, José de Armas, Kara M. Hoar, J Blazej, R. Scott Rowland, Muhamad Danuri, Shishita Jahan Zisha, He N. Xu	2013	37
7	A Selective Cannabinoid-1 Receptor Antagonist, PF-95453, Reduces Body Weight and Body Fat to a Greater Extent than Pair-Fed Controls in Obese Monkeys Journal of Pharmacology and Experimental Therapeutics ·Janice D. Wagner, Li Zhang, Kylie Kavanagh, A. C. P. ORO, Janice E. Chin, John R. Hadcock, Bruce J. Auerbach, H. James Harwood	2010	20
8	Galanin function in the central nervous system. PubMed ·Kevin M. Walton, Janice E. Chin, Allen J. Duplantier, Robert J. Mather	2006	18
9	Synthesis of Novel 2,4-Diaminopyrrolo[2,3-d]pyrimidines with Antioxidant, Neuroprotective, and Antiasthma Activity Journal of Medicinal Chemistry ·Gordon L. Bundy, Donald E. Ayer, Lee S. Banitt, Kenneth L. Belonga, S. A. MIZSAK, Julie R. Palmer, J. M. Tustin, Janice E. Chin, Edward D. Hall	1995	48
10	Substrates and signalling complexes: The tortured path to insulin action Journal of Cellular Biochemistry ·Richard A. Roth, Barkah Hamzah Nasution, Janice E. Chin, Kristina S. Kovacina	1992	28
11	Characterization of insulin-stimulated protein serine/threonine kinases in CHO cells expressing human insulin receptors with point and deletion mutations Biochemical Journal ·Martin Dickens, Janice E. Chin, Richard A. Roth, L Ellis, Richard M. Denton, Jeremy M. Tavaré	1992	44
12	Sequence and molecular characterization of human monocyte/neutrophil elastase inhibitor. Proceedings of the National Academy of Sciences ·Eileen Remold‐O’Donnell, Janice E. Chin, Mark J. Alberts	1992	121
13	Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proceedings of the National Academy of Sciences ·Kevin E. Noonan, Christian Beck, Tatyana A. Holzmayer, Janice E. Chin, Jay S. Wunder, Irene L. Andrulis, Adi F. Gazdar, Cheryl L. Willman, Barbara Griffith, Daniel D. Von Hoff, Igor B. Roninson Hit paper breakdown →	1990	660
14	Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells Cell ·C J J Westermann, Janice E. Chin, Kazumitsu Ueda, Douglas P. Clark, Ira Pastan, Michael M. Gottesman, Igor B. Roninson Hit paper breakdown →	1986	1660
15	Multidrug resistance of DNA-mediated transformants is linked to transfer of the human mdr1 gene. Molecular and Cellular Biology ·Donglai Shen, Antonio Tito Fojo, Igor B. Roninson, Janice E. Chin, Sri Alvina Damayanti, Ira Pastan, M M Gottesman	1986	81
16	Multidrug Resistance of DNA-Mediated Transformants is Linked to Transfer of the Human mdr1 Gene Molecular and Cellular Biology ·Ding‐Wu Shen, Antonio Tito Fojo, Igor B. Roninson, Janice E. Chin, Sri Alvina Damayanti, Ira Pastan, Michael M. Gottesman	1986	133
17	Localization of multidrug resistance-associated DNA sequences to human chromosome 7 Somatic Cell and Molecular Genetics ·Antonio Tito Fojo, R V Lebo, Nobutaka Shimizu, Janice E. Chin, Igor B. Roninson, Glenn Merlino, Michael M. Gottesman, Ira Pastan	1986	69
18	Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proceedings of the National Academy of Sciences ·Igor B. Roninson, Janice E. Chin, Kyoung‐Gyu Choi, Piet Gros, David E. Housman, Antonio Tito Fojo, Donglai Shen, Michael M. Gottesman, I Pastan Hit paper breakdown →	1986	558
19	Human Multidrug-Resistant Cell Lines: Increased mdr 1 Expression Can Precede Gene Amplification Science ·Donglai Shen, Antonio Tito Fojo, Janice E. Chin, Igor B. Roninson, Nancy Richert, Ira Pastan, Michael M. Gottesman Hit paper breakdown →	1986	528
20	DNA Polymorphism of the C4 Genes New England Journal of Medicine ·Alexander S. Whitehead, D E Woods, E. Fleischnick, Janice E. Chin, Edmond J. Yunis, Aubrey J. Katz, Park S. Gerald, Chester A. Alper, Harvey R. Colten	1984	74

About Janice E. Chin

Janice E. Chin is a scholar working on Aging, Oncology, Software, Molecular Biology and Virology, having authored 22 papers that have together received 4.4k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (10 papers), Cancer therapeutics and mechanisms (7 papers), DNA Repair Mechanisms (3 papers), Pediatric Hepatobiliary Diseases and Treatments (2 papers), Protein Degradation and Inhibitors (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Peptidase Inhibition and Analysis (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Oncology (3.1k citations), Molecular Biology (2.4k citations), Pediatrics, Perinatology and Child Health (621 citations), Infectious Diseases (550 citations) and Pharmacology (215 citations). Janice E. Chin has collaborated with scholars based in United States, Brazil and India. Frequent co-authors include Igor B. Roninson, Michael M. Gottesman, Ira Pastan, Douglas P. Clark, Kazumitsu Ueda, Antonio Tito Fojo, Donglai Shen, Kevin E. Noonan, Nancy Richert and Kyoung‐Gyu Choi. Their work appears in journals such as Molecular and Cellular Biology, Proceedings of the National Academy of Sciences, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry and Molecular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact